The Innovation and Technology Day, an open forum for technology pioneers, entrepreneurs, policy-makers, and experts, designed to facilitate dialogue and action on key issues related to innovation, technology and development, is a joint initiative of the United Nations Conference on Trade and Development (UNCTAD) and the Qatar Foundation.
MedMira Inc, based in Halifax, Nova Scotia is a leading developer and manufacturer of flow-through rapid diagnostics and technologies. The company's tests provide hospitals, labs, clinics and individuals with reliable, rapid diagnosis for diseases such as HIV and hepatitis C in just three minutes. MedMira's rapid flow-through HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union.
"It is a privilege to be invited to speak at UNCTAD XIII about innovation, something which I am very passionate about and which is at the heart of everything we have done and continue to accomplish at MedMira," said Hermes Chan, CEO, MedMira, to Canada Newswire.
"Sharing the MedMira vision in this world class international forum is a great honour and an exciting opportunity to build key relationships with organizations such as UNCTAD, the Qatar Foundation, and other agencies working to further economic sustainability in developing countries through innovation and technology."
Mr. Chan will be taking the stage to speak about the inspiration behind MedMira and his experiences in creating and commercializing the Company's patented rapid diagnostics technology platform and diagnostic applications as well as the impact of these innovations on both healthcare and economic growth in developing countries.